Trial | NCT01369238  Report issue

Title

East-West Collaborative Medicine Using Bee-Venom Acupuncture on Whiplash-Associated Disorders
Clinical Research on the Efficacy of East-West Collaborative Medicine Using Bee-Venom Acupuncture Therapy on Whiplash-Associated Disorders After Traffic Collisions; A Randomized, Controlled, Parallel Trial

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Unknown status

  • Study Participants

    90
Purpose of study

To evaluate the efficacy of East-West collaborative medicine using Bee-Venom Acupuncture Therapy on Whiplash-Associated Disorders using VAS scale
To evaluate the efficacy of East-West collaborative medicine using Bee-Venom Acupuncture Therapy on Whiplash-Associated Disorders using NDI, BDI, SF-36, and EQ-5D.

Interventions & Groups

group 1: Bee-Venom Acupuncture Therapy
group 2: zaltoprofen
group 3: Bee-Venom Acupuncture Therapy & zaltoprofen
Study Started
Jun 30
2011
Primary Completion
Jan 31
2012
Anticipated
Study Completion
Mar 31
2012
Anticipated
Last Update
Jun 08
2011
Estimate

Device Bee Venom Acupuncture Therapy

1:4000, SC 1cc/day, 2~3days/wk, for 1 month

  • Other names: pharmacoacupuncture

Drug zaltoprofen

80mg/Tab, per os 1Tab tid, for 2 months

  • Other names: soleton

Bee Venom Acupuncture & zaltoprofen Experimental

zaltoprofen Active Comparator

Bee Venom Acupuncture Active Comparator

Criteria 

Inclusion Criteria:

clinical diagnosis of Whiplash injuries
Must have cervicalgia of more than VAS 5

Exclusion Criteria:

cancer, osteoporosis, ankylosing spodylitis, cauda equina syndrome, infection
spinal operation
other musculoskeletal pain
physicological or mental disorders
No Results Posted